Market Research Report
Global Biosimilars Market - Products, Applications and Regulations
|Published by||Industry Experts||Product code||839490|
|Published||Content info||364 Pages, 223 Charts
Delivery time: 1-2 business days
|Global Biosimilars Market - Products, Applications and Regulations|
|Published: May 9, 2019||Content info: 364 Pages, 223 Charts||
Cost effectiveness, increasing geriatric population, rising incidences and prevalence of chronic ailments such as Cancer, Autoimmune Disorders and Diabetes and supportive government regulations and guidelines are some of the factors fueling the biosimilars market. Patent expiry of most of the monoclonal antibody based biologics drives the biosimilar monoclonal antibody market. Oncology biosimilar market leads the biosimilars market and is primarily driven by the rising prevalence and incidence of cancer and patent expiry of the expensive biologics. On the other hand, the growth of the biosimilars market is retarded due to insufficient regulatory guidelines, expensive research and development procedures and preference of patented products by the patients, etc.
Monoclonal Antibodies constitute the single largest product type in the global Biosimilars market, demand for which is estimated at US$4.4 billion in 2018 and is projected to reach US$28.8 billion by 2025. The overall Biosimilars market in 2019 is expected to reach US$10.4 billion.
The report analyzes the market for the following key product types of Biosimilars:
Therapeutic areas of Biosimilars analyzed in this study comprise the following:
The report reviews, analyzes and projects the global Biosimilars market for the period 2016-2025 in terms of US$ and the compound annual growth rates (CAGRs) projected from 2018 through 2025.